gsk-4112 gsk-4112 gsk-4112 is an experimental drug that was developed by glaxosmithkline as an agonist of rev-erbaα. it is used for studying regulation of the circadian rhythm and its influence on diverse processes such as adipogenesis, regulation of bone density, and inflammation. gsk-4112identifiers iupac name tert-butyl 2-amino]acetate cas number1216744-19-2pubchem cid50905018chemspider24606038chemblchembl1961795chemical and physical dataformulac18h21cln2o4smolar mass396.89 g·mol−13d model (jsmol)interactive image smiles cc(c)(c)oc(=o)cn(cc1=cc=c(c=c1)cl)cc2=cc=c(s2)(=o) inchi inchi=1s/c18h21cln2o4s/c1-18(2,3)25-17(22)12-20(10-13-4-6-14(19)7-5-13)11-15-8-9-16(26-15)21(23)24/h4-9h,10-12h2,1-3h3key:wyslokhvfklwou-uhfffaoysa-n